Anthropic launches Claude Science AI tool for research
Anthropic has launched Claude Science, a new AI tool designed for scientific research, particularly in computational biology and drug discovery. The product is now available to paying Claude subscribers.
What happened?
On 30 June 2026, Anthropic presented Claude Science at an event for pharmaceutical executives, biotechnology founders, and researchers. The product is designed to autonomously perform research work based on high-level instructions and has access to tools tailored for computational biology and drug discovery. Claude Science is now available to all paying Claude subscribers.
Key facts
| Lansering | 30 juni 2026 |
|---|---|
| Produkt | Claude Science |
| Fokusområden | Beräkningsbiologi, läkemedelsutveckling |
| Tillgänglighet | Alla betalande Claude-prenumeranter |
”At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering.”
”Like Claude Code, Claude Science can autonomously carry out meaningful work when given concise, high-level instructions, and it has access to tools that make it particularly useful for research in computational biology and drug development.”
”Along with launching and previewing Claude Science, which is now available to all paid Claude subscribers, Anthropic also announced that it will be using the product to pursue some of its own research into drugs for rare, neglected diseases.”
Why it matters
The launch of Claude Science signals that Anthropic is strategically investing in AI applications for science. By positioning Claude Science alongside existing products such as Claude Code, the company emphasises the importance of AI in driving innovation within research and development, particularly in the life sciences sector.
Who is affected?
The product aims to support researchers in fields such as computational biology and drug discovery. Pharmaceutical companies, biotechnology firms, and individual researchers with paid Claude subscriptions are the primary user groups. Anthropic will also utilise Claude Science for its own internal research on rare diseases.
What else you should know
Anthropic previously released plugins for scientific software under the name 'Claude for Life Sciences', but Claude Science represents a more comprehensive and standalone product. The company will conduct its own research into rare diseases using the tool.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Vilka bolag berörs?
The link opens in a new window and leads to the publisher's own site.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.
AI-verktyg i artikeln
Topics
Get similar news straight to your inbox
The reader's room
Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.
Sign in to submit a comment or question.
Read the article through your role
- Decide whether this affects strategy over 6–12 months or is just noise.
- Discuss with leadership: do we own the right question or does ownership need to move?
- Ask: what risk are we taking by NOT acting on this this quarter?
Generated angle — not editorial analysis of "Anthropic launches Claude Science AI tool for research"